NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BrightGene Bio-Medical Technology Co. Ltd (SHG: 688166)

 
688166 Technical Analysis
2
As on 15th Dec 2025 688166 STOCK Price closed @ 49.94 and we RECOMMEND Sell for LONG-TERM with Stoploss of 55.29 & Strong Buy for SHORT-TERM with Stoploss of 30.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

688166STOCK Price

Open 52.80 Change Price %
High 53.18 1 Day -3.24 -6.09
Low 49.72 1 Week -1.83 -3.53
Close 49.94 1 Month -8.22 -14.13
Volume 14904430 1 Year 18.34 58.04
52 Week High 116.49 | 52 Week Low 28.77
 
SHG China Most Active Stocks
601933 5.05 1.00%
600705 3.47 0.29%
600811 0.36 -2.70%
601399 5.38 3.86%
601989 5.10 1.80%
601179 9.60 5.73%
600157 1.61 0.62%
600734 5.85 3.36%
600879 15.82 10.01%
601106 3.79 -2.57%
 
SHG China Top Gainers Stocks
688418 41.15 15.79%
688600 25.40 11.99%
600462 0.21 10.53%
601778 3.71 10.09%
600408 5.03 10.07%
603871 14.25 10.04%
600186 5.81 10.04%
600730 15.91 10.03%
601908 4.28 10.03%
601208 21.84 10.03%
 
SHG China Top Losers Stocks
603958 13.40 -10.01%
601869 95.15 -10.00%
603360 30.55 -9.99%
600200 0.37 -9.76%
688466 15.93 -9.54%
603506 12.11 -9.42%
601566 13.66 -9.12%
600302 9.93 -8.98%
603386 15.00 -8.81%
688266 100.00 -8.60%
 
 
688166
Daily Charts
688166
Intraday Charts
Whats New @
Bazaartrend
688166
Free Analysis
 
688166 Important Levels Intraday
RESISTANCE56.61
RESISTANCE54.47
RESISTANCE53.15
RESISTANCE51.83
SUPPORT48.05
SUPPORT46.73
SUPPORT45.41
SUPPORT43.27
 
688166 Forecast December 2025
4th UP Forecast57.69
3rd UP Forecast55.2
2nd UP Forecast53.67
1st UP Forecast52.13
1st DOWN Forecast47.75
2nd DOWN Forecast46.21
3rd DOWN Forecast44.68
4th DOWN Forecast42.19
 
688166 Weekly Forecast
4th UP Forecast54.37
3rd UP Forecast52.95
2nd UP Forecast52.07
1st UP Forecast51.19
1st DOWN Forecast48.69
2nd DOWN Forecast47.81
3rd DOWN Forecast46.93
4th DOWN Forecast45.51
 
688166 Forecast2025
4th UP Forecast231.35
3rd UP Forecast173.17
2nd UP Forecast137.21
1st UP Forecast101.25
1st DOWN Forecast-1.37
2nd DOWN Forecast-37.33
3rd DOWN Forecast-73.29
4th DOWN Forecast-131.47
 
 
688166 Other Details
Segment EQ
Market Capital 12615700480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
688166 Address
688166
 
688166 Latest News
 
Your Comments and Response on BrightGene Bio-Medical Technology Co. Ltd
 
688166 Business Profile
BrightGene Bio-Medical Technology Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of medicines, and generic APIs and FDFs in China. Its product pipeline includes immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, and novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis. The company also develops Eribulin, Trabectedin, Fondaparinux, Caspofungin, and non-biological molecules; macromolecules, such as Ferumoxytol and Ferric pyrophosphate citrate; and ADC cytotoxic payloads comprising Maytansinoids, Auristatins, and Calicheamicin. It offers cardiovascular, antibacterial, ADC, oncology, antifungal, iron supplement, anti-HBV, veterinary, and immuno products. The company was founded in 2001 and is based in Suzhou, China. Address: Building C25-28, Suzhou, China, 215123
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service